NCT01820208View on ClinicalTrials.gov

Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 1, 2014

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions
Severe Alcoholic Hepatitis
Interventions
DRUG

G-CSF

G-CSF would be given at a dose of 5 microgram/kg daily for 5 days followed by once in 3 days for a total of 12 doses.

DRUG

Placebo

Placebo would be given s/c at days 1, 2, 3, 4, 5 and then every 3rd day till day 28 (total 12 doses)

Trial Locations (1)

110070

Institute of liver and Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT01820208 - Efficacy of G-CSF in the Management of Steroid Non-responsive Severe Alcoholic Hepatitis | Biotech Hunter | Biotech Hunter